Westford USA, Aug. 04, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, governments across different countries are increasingly supporting the biopharmaceutical and pharmaceutical companies in their ...
Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to FDA statistics. Over the last decade the industry has exhausted resourcing to low-cost ...
Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral ...
PROMIS Centre, a research centre focused on the development of methods for analysis and optimisation of pharmaceutical processes, has built a new and unique continuous processing pharmaceutical ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Digital twins — a digital replica of the factory floor — are an important ...
In this Drug Digest video, our speakers will discuss aseptic processing and the manufacturing portion of the process. Join the Drug Digest video to help prepare for manufacturing and barriers that ...
Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for pharmaceutical manufacturing. Flexibility in pharmaceutical manufacturing is becoming ...
The Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to reach a value of USD 2196 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 12.95% ...
Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...
Emirates News Agency on MSN
Julphar signs lease agreement with Modon Industrial City for its integrated pharmaceutical manufacturing facility in Saudi Arabia
Following the earlier announcement to establish an integrated pharmaceutical manufacturing facility in the Kingdom of Saudi ...
In today’s Pharmaceutical Executive Daily, Eli Lilly reports positive topline Phase III results for retatrutide, the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results